title: Marked hypertriglyceridemia upon treatment with etanercept.
authors.forename: Muhammad
authors.initials: M
authors.lastname: Haroon
authors.forename: Joe
authors.initials: J
authors.lastname: Devlin
mesh_terms: D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000097:blood / Q000188:drug therapy*; D002784:Cholesterol / Q000097:blood; D000068800:Etanercept; D006801:Humans; D015228:Hypertriglyceridemia / Q000097:blood / Q000139:chemically induced*; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000627:therapeutic use; D008075:Lipoproteins, HDL / Q000097:blood; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
chemical_list: D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D008075:Lipoproteins, HDL; D018124:Receptors, Tumor Necrosis Factor; D014280:Triglycerides; D002784:Cholesterol; D000068800:Etanercept; D008727:Methotrexate